Yale Medicine, an academic medical center with a high volume of prostate biopsies, conducted a study to determine Paige Prostate’s utility as a prescreening tool for clinical use. A total of 1,876 prostate core biopsy slides were analyzed by Paige Prostate, and only those cores categorized by the AI as “suspicious” or as out of distribution were manually reviewed by Yale pathologists.
With assistance from AI, the study found:
- Pathologists had to manually review only 31.4% of biopsies, signaling that Paige Prostate could substantially increase pathologist productivity in practice.
- Paige Prostate was shown to increase detection of prostate cancer when reviewed by non-GU subspecialized pathologists.